69 related articles for article (PubMed ID: 17086891)
1. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.
Chan CC; Chien NH; Lee CL; Yang YC; Hung CS; Tu TC; Wu CH
BMC Gastroenterol; 2015 Dec; 15():170. PubMed ID: 26635102
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers.
Silva FM; Queiroz EC; Navarro-Rodriguez T; Barbuti RC; Mattar R; Iriya K; Lee JH; Eisig JN
Clinics (Sao Paulo); 2015 May; 70(5):318-21. PubMed ID: 26039946
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of seven Chinese patent medicines combined with conventional triple/quadruple therapy for
Jiang Z; Deng B; Zhang Y; Li Y; Yu Z; Deng H; Chen Y
BMJ Open; 2024 Apr; 14(4):e074188. PubMed ID: 38684278
[TBL] [Abstract][Full Text] [Related]
4. Randomised clinical trial: efficacy and safety of H. pylori eradication treatment with and without Saccharomyces boulardii supplementation.
Sjomina O; Poļaka I; Suhorukova J; Vangravs R; Paršutins S; Knaze V; Park JY; Herrero R; Murillo R; Leja M
Eur J Cancer Prev; 2024 May; 33(3):217-222. PubMed ID: 37942999
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Hou Gu Mi Xi for peptic ulcer diseases: Study protocol for a randomized controlled trial.
Chen X; Yan D; Fang J; Liu W; Nie H; Lv N; Fang N; Gong J; Yu J; Jiang Y; Liu Z; Gan H; Fu Y; Yang D; Xiong Y; Liu D; Chen M; Wang Y; Wang Y; Sun X; Zhou X; Zhu W
Medicine (Baltimore); 2019 Jul; 98(29):e16561. PubMed ID: 31335741
[TBL] [Abstract][Full Text] [Related]
6. New Diagnostic Strategies for Detection of Helicobacter pylori Infection in Pediatric Patients.
Gold BD; Gilger MA; Czinn SJ
Gastroenterol Hepatol (N Y); 2014 Dec; 10(12 Suppl 7):1-19. PubMed ID: 26491414
[TBL] [Abstract][Full Text] [Related]
7. Antiulcer Agents: From Plant Extracts to Phytochemicals in Healing Promotion.
Sharifi-Rad M; Fokou PVT; Sharopov F; Martorell M; Ademiluyi AO; Rajkovic J; Salehi B; Martins N; Iriti M; Sharifi-Rad J
Molecules; 2018 Jul; 23(7):. PubMed ID: 30018251
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of gastroretentive dosage forms of Clarithromycin.
Nama M; Gonugunta CS; Reddy Veerareddy P
AAPS PharmSciTech; 2008; 9(1):231-7. PubMed ID: 18446486
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Syferol-IHP for the treatment of peptic ulcer disease: a pilot, double-blind randomized trial.
Eleje GU; Ogbunugafor HA; Emegoakor CD; Okoye EI; Ezejiofor OI; Chukwurah SN; Ikechebelu JI; Nchinda GW; Ugochukwu CG; Nnaji-Ihedinmah LI; Okoye FBC; Eneh FU; Onwukamuche ME; Esimone CO
Clin Exp Gastroenterol; 2019; 12():21-30. PubMed ID: 30679917
[TBL] [Abstract][Full Text] [Related]
10. Micromotor-enabled active drug delivery for in vivo treatment of stomach infection.
de Ávila BE; Angsantikul P; Li J; Angel Lopez-Ramirez M; Ramírez-Herrera DE; Thamphiwatana S; Chen C; Delezuk J; Samakapiruk R; Ramez V; Obonyo M; Zhang L; Wang J
Nat Commun; 2017 Aug; 8(1):272. PubMed ID: 28814725
[TBL] [Abstract][Full Text] [Related]
11. Simple patch closure for perforated peptic ulcer in children followed by helicobacter pylori eradication.
Yildiz T; Ilce HT; Ceran C; Ilce Z
Pak J Med Sci; 2014 May; 30(3):493-6. PubMed ID: 24948965
[TBL] [Abstract][Full Text] [Related]
12. Response to Article "
Yuliandari P; Maha MS; Panjaitan NSD
Int J Nanomedicine; 2024; 19():2993-2994. PubMed ID: 38544952
[No Abstract] [Full Text] [Related]
13. Nutritional care in peptic ulcer.
Vomero ND; Colpo E
Arq Bras Cir Dig; 2014; 27(4):298-302. PubMed ID: 25626944
[TBL] [Abstract][Full Text] [Related]
14. Drug utilization of clarithromycin for gastrointestinal disease treatment.
Zhou Q; Zhu LL; Yan XF; Pan WS; Zeng S
World J Gastroenterol; 2008 Oct; 14(39):6065-71. PubMed ID: 18932287
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease.
Liou JM; Chen CY; Wu MS; Hsu MT; Fang CC; Lin YL; Chang MC; Lin JT; Wang HP
Hepatogastroenterology; 2006; 53(71):792-6. PubMed ID: 17086891
[TBL] [Abstract][Full Text] [Related]
16. One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing.
Hsu CC; Lu SN; Changchien CS
Hepatogastroenterology; 2003; 50(53):1731-4. PubMed ID: 14571829
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
[TBL] [Abstract][Full Text] [Related]
18. Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials.
Laine L; Fennerty MB; Osato M; Sugg J; Suchower L; Probst P; Levine JG
Am J Gastroenterol; 2000 Dec; 95(12):3393-8. PubMed ID: 11151867
[TBL] [Abstract][Full Text] [Related]
19. Review article: esomeprazole in the treatment of Helicobacter pylori.
Laine L
Aliment Pharmacol Ther; 2002 Jul; 16 Suppl 4():115-8. PubMed ID: 12047270
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
